Aeglea BioTherapeutics (AGLE) Says Data Shows AEB3103 Suppresses Cancer Growth in Preclinical Models
Go back to Aeglea BioTherapeutics (AGLE) Says Data Shows AEB3103 Suppresses Cancer Growth in Preclinical Models| Angel Entertainment Inc (NASDAQ: AGLE) | Delayed: 12.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.01 | 52 Week High | $12.75 | |||
| Open | $12.01 | 52 Week Low | $3.89 | |||
| Day High | $12.01 | P/E | N/A | |||
| Day Low | $12.01 | EPS | $0.00 | |||
| Volume | 574 | |||||
